References
- Coccia-Portugal MA, Sidling WL, Terblanche AP, et al. Aspergillus brain abscess: a case report. S Africa Med J 1987;71:116–118.
- Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis. 1996;23:608–615.
- Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Rev Infect Dis. 1990;12:1147–1182.
- Hagenese ME, Bauwens JE, Kjos B, et al. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Centre 1984-1992. Clin Infect Dis. 1995;19:402–408.
- Beal MF. Cerebral aspergillosis. NY State J Med. 1988;88:620–622.
- Schaffner A, Doughlas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest. 1982;69:617–631.
- Ng T, Robson GD, Denning DW. Hydrocortsone enhanced growth of Asp ergillus spp: implication for pathogenesis. Microbiology. 1994;140:2475–2479.
- Berner R, Sauter S, Michalski y et al. Central venous catheter infection by Aspergillus fumigatus in a patient with B-type non-Hodgkin lymphoma. Med Pediats Oncol. 1996;27:202,204.
- Roilides E, Holmes A, Blake C, et al. Antifungal activity of elutriated human monocytes against Aspergillus fumigatushyphae: enhancement by granulocyte-macrophage colony stimulating factor and interferon-gamma. J Infect Dis. 1994;170:894–899.
- Nemunaitis J. Use of macrophage colony stimulating factor in the treatment of fungal infections. Clin Infect Dis. 1998;26:1279–1281.